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Abstract.  Schwann cells synthesize two heparan sul- 
fate proteoglycans, one that is a component of the 
Schwann cell basement membrane and a smaller one 
that is an integral component of the Schwann cell 
plasma membrane. To determine the functions of these 
molecules, Schwann cell-nerve cell cultures were 
grown in medium containing a specific  inhibitor of 
proteoglycan biosynthesis, 4-methylumbelliferyl-13-D- 
xyloside. Treatment with 1 mM 13-D-xyloside caused a 
90%  reduction in the accumulation of ssSO4-1abeled 
proteoglycans in the cell layer of the cultures. Gel 
filtration analysis revealed that both the basement 
membrane and plasma membrane proteoglycans were 
affected. Inhibition of proteoglycan biosynthesis was 
accompanied by an inhibition of laminin deposition 
into extracellular matrix as determined by immuno- 
staining of cultures and by immunoblotting of cell- 
associated proteins. This occurred even though there 
was no decrease in the amount of laminin detected in 
the medium of 13-D-xyloside-treated cultures. Deposi- 
tion of collagen type IV was similarly affected. In ad- 
dition, there was no myelin produced in 13-D-xyloside 
treated cultures. However,  when 13-xyloside-treated 
cultures were supplied with exogenous basement mem- 
brane, Schwann cells produced numerous myelin 
segments. These results indicate that Schwann cell 
proteoglycans play an essential role in basement 
membrane assembly, and that the integral plasma 
membrane proteoglycan is not required for the base- 
ment membrane to exert its effects on Schwann cell 
differentiation. 
T 
HE  extracellular  matrix  (ECM) 1 plays an  essential 
role in the development of  many tissues, affecting such 
cellular functions as adhesion, migration, cell shape, 
proliferation,  and gene expression (reviewed by Hay [14]). 
The ability to purify several of  the major molecular constitu- 
ents of the ECM has made it possible to study their proper- 
ties in detail, and is beginning to provide an understanding 
of ECM action at the molecular level. 
An example of a  cell whose  development is dependent 
upon ECM contact is the Schwann cell. The principal func- 
tion of Schwann cells is to provide myelin and unmyelinated 
ensheathment  for  peripheral  nerve  fibers.  In  addition, 
Schwann cells synthesize a portion of the peripheral  nerve 
connective tissue matrix, including the basement membrane 
that surrounds each Schwann cell axon unit (4-8, 11, 28, 29). 
Experiments  performed  with  primary  tissue  cultures  of 
Schwann cells and nerve cells have demonstrated that contact 
with this basement membrane by Schwann cells is essential 
for their ensheathment and myelination of axons (6, 10, 30). 
These findings have led to investigations into the biochemi- 
cal composition of the Schwann cell ECM, with the goal of 
understanding the mechanism of its effect on Schwann cell 
differentiation.  These  experiments  have  established  that 
1. Abbreviations used in this paper: ECM, extracellular matrix; HS, hepa- 
ran sulfate; PG, proteoglycan. 
Schwann cells synthesize several collagen types (5), includ- 
ing collagen type IV (8), the basement membrane glycopro- 
tein  laminin  (11), and  two  heparan  sulfate  proteoglycans 
(HS-PGs) (29). Biochemical studies of these HS-PGs have 
revealed that one is a component of the Schwann cell base- 
ment membrane, and the other is an integral component of 
the Schwann cell plasma membrane (9, 29). 
It is of interest to determine the role these HS-PGs play 
in Schwann cell development. Investigations into the func- 
tions of PGs have been hampered by the difficulty of purify- 
ing these molecules in an intact, native state. For this reason 
most studies assessing PG function have relied upon cor- 
relating the absence or presence of these molecules with al- 
terations in particular cellular functions. This has been done 
by correlating changes in PG metabolism with cellular func- 
tion (2, 41), or by removing PGs, either with enzymes (17) 
or by using drugs which specifically inhibit PG biosynthesis 
(26, 34,  38). 
We  have  used  4-methylumbelliferyl-13-o-xyloside as  a 
specific inhibitor of PG biosynthesis to investigate the func- 
tions of the Schwann cell HS-PGs. In this paper we present 
evidence that inhibition of PG biosynthesis in rat Schwann 
cell-nerve cell primary cultures  prevents basement  mem- 
brane  deposition as well as myelin formation by Schwann 
cells. The inhibition of myelin formation by Schwann cells 
can be reversed, however, by supplying these cultures with 
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HS-PGs are required for assembly of the Schwann cell base- 
ment membrane. Furthermore, Schwann cells are capable of 
myelin formation in response to exogenous basement mem- 
brane contact even under conditions in which they lack their 
cell surface HS-PG. 
Materials and Methods 
Cell Culture 
Primary dissociated cultures containing only Schwann cells and sensory 
nerve cells were prepared by previously published methods (4, 7,  10, 30). 
Briefly,  dorsal root ganglia were dissected from rat embryos, dissociated 
with trypsin, and seeded onto 2-cm diam Aclar mini-dishes coated with col- 
lagen type I (from rat tail tendons). For the first 5-7 d the cultures were fed 
an antimitotic medium containing 10  -5 M  5-fluorodeoxyuridine and  10% 
FCS.  The cultures were then maintained in the serum-free medium N2. 
Schwann cell basement membrane production was initiated by switching the 
cultures to N2 supplemented with ascorbic acid (50  I~g/ml) and BSA (1 
mg/ml) (supplemented N2) (Carey,  D. J., and M. S. Todd, manuscript sub- 
mitted for publication). For cultures grown with exogenous basement mem- 
brane, dorsal root ganglion explants previously grown for 1 wk oh type I 
collagen in antimitotic medium were transferred to basement membrane- 
coated dishes; dissociated cultures grown in N2 medium for 3-4 wk were 
embedded in basement membrane gel as described earlier (10). 
Basal media components were from Gibeo Laboratories (Grand Island, 
NY). Sera were obtained from KC Biologicals (Lenexa, KS); other medium 
additives were from Sigma Chemical Co. (St. Louis, MO). Solubilized ma- 
trix proteins from the Englebreth-Holm swarm sarcoma used to prepare 
reconstituted basement membrane (20)  were generously provided by Dr. 
Hynda Kleiuman, National Institutes of Health. 
PG Analysis 
PGs  were  labeled  by  incubating  cultures  in  Ham's  F12  medium  sup- 
plemented with transferrin (100 Ixg/rnl), insulin (5 ~tg/mi), and 200 I.tCi/mi 
35SO4 (carrier-free, from ICN Radiochemicals, Irvine, CA) as described 
previously (9,  29).  After incubation,  culture media were harvested and 
mixed with protease inhibitors (10 mM EDTA, 1 mM phenylmethylsulfonyl 
fuuride). The cells and matrix were solubilized in guanidine buffer (4 M 
guanidine-HCl, 50 mM sodium acetate, 10 mM EDTA, 0.1% Triton X-100, 
1 mM phenylmethylsulfonyl fluoride). Unincorporated 35SO4 was removed 
by chromatography on a  Sephadex G-50 column eluted with guanidine 
buffer.  Molecules that eluted in the void volume fractions were pooled and 
an  aliquot was counted to determine the total  35SO4 incorporation.  The 
pooled fractions were applied to a 1 x  100-cm column of Sepharose C1-4B 
and eluted with guanidine buffer at a flow rate of  6 ml/h. Alkaline hydrolysis 
was carried out in 0.05  M  NaOH,  1 M NaBI-14 at 45 °  for 16 h.  Nitrous 
acid hydrolysis was in 0.25 M NaNO2,  1.9 M acetic acid at room tempera- 
ture for 2 h. 
lmmunofluorescence 
Indirect immunofluorescence was carried out on whole-mount preparations 
of primary cultures as described previously (8, 11). The cultures were rinsed 
with Leibovitz L-15 medium containing 10% heat-inactivated horse serum 
and incubated for 1 h at 4°C with rabbit antiserum specific for laminin or 
collagen type IV  (diluted  1:20  in  L15-horse serum).  The cultures were 
rinsed  and  then  incubated  for  1  h  at  4°C  with  affinity-purified goat 
anti-rabbit IgG (Sigma Chemical Co.).  After rinsing, the cultures were 
fixed for 1 h at room temperature with 3 % paraformaldehyde, mounted on 
glass slides, and viewed with a Nikon Diaphot inverted microscope (Nikon, 
Inc., Garden City, NY) equipped for epifluorescence. 
lmmunoblotting 
Aliquots of conditioned culture medium or cells (extracted with 0.0625  M 
Tris-HC1,  2%  SDS, pH 6.8)  were subjected to electrophoresis in SDS- 
polyacrylamide slab gels prepared according to the method of Laemmli (21). 
After running, the gels were soaked for 30 min in transfer buffer (12.5 mM 
Tris base, 96 mM glycine) and electrophoretically transferred to nitrocellu- 
lose sheets (BioRad Laboratories, Richmond, CA) at a constant voltage of 
70 V for 40 min. After transfer the nitrocellulose sheets were soaked for 
1 h in blocking solution (BLOTTO, 50 mM Tris-C1, pH 7.4,  100 mM NaCI, 
5% Carnation nonfat dry milk [16]). The sheets were then incubated over- 
night at 4°C in first antibody solution (diluted 1:100 or 1:250 in BLOTTO). 
After rinsing with BLOTTO, the sheets were incubated for 2 hr in a solution 
containing affinity-purified goat anti-rabbit IgG conjugated to horseradish 
peroxidase (BioRad Laboratories, diluted 1:3,000 in BLO'I'TO).  After rins- 
ing, the bound antibodies were visualized by their peroxidase reaction prod- 
ucts with 4-chloro-l-naphthol as substrate. 
Antisera 
Antisera to laminin and collagen type IV were produced in rabbits by multi- 
ple subcutaneous injections of the purified proteins (100-200  I~g/injection; 
obtained from Bethesda Research Laboratories, Gaithersburg, MD) in com- 
plete (first injection) or incomplete Freund's adjuvant. Antibody specificity 
and titer were tested by staining of proteins transferred to nitrocellulose as 
described above. 
Myelin Formation 
Myelin formation was assessed by examining the living cultures in a Nikon 
Diaphot inverted microscope using bright-field optics. As reported previ- 
ously, structures that can be identified as myelin by immunostaining and 
histologic staining can be clearly visualized using this method (10). 
Results 
Effects of  4-Methylumbelliferyl-~-o-Xyloside 
on Schwann Cell PG Synthesis 
To examine the effects of the PG biosynthesis inhibitor on 
Schwann cells we used primary dissociated cultures of rat 
Schwann cells and nerve cells which were grown initially 
(for  4  wk)  in  N2  medium.  Cultures  maintained  in  N2 
medium produce a dense network of nerve fibers which be- 
come populated with Schwann cells that proliferate in re- 
sponse to nerve fiber contact (30,  35, 36). In this medium, 
however, Schwann cells do not produce EMC and do not my- 
elinate nerve fibers (7, 29). ECM production and myelina- 
tion were induced in these cultures by switching them to N2 
medium supplemented with ascorbic acid (50 I~g/ml) and 
BSA (1 mg/ml) (supplemented N2) (Carey, D. J., and M. S. 
Todd, manuscript submitted for publication). This medium 
switch results in the deposition into ECM of laminin, colla- 
gen type IV, and the basement membrane HS-PG (29; Carey, 
D. J., and M.  S.  Todd, manuscript submitted); the plasma 
membrane HS-PG is present in approximately the same lev- 
els in both N2 medium and supplemented N2 (29). 
To test the effect of the PG synthesis inhibitor on Schwann 
cell HS-PG synthesis,  the drug  was  added to the  culture 
medium at the time of switching to supplemented N2, i.e., 
at the time of initiation of basement membrane formation. 
Sibling cultures switched to supplemented N2 but without 
inhibitor served as controls. After 1 wk the cultures were la- 
beled with 3sSO4 for 18 h and the medium and cell-associ- 
ated  35SO4-1abeled macromolecules were  quantitated  and 
analyzed by gel filtration chromatography. 
As  shown in  Table I,  incorporation of 35SO4 into  cell- 
associated macromolecules was reduced to 24 % of control 
by  1 mM  [I-xyloside, whereas  incorporation into culture 
medium  macromolecules was  increased  nearly  threefold. 
These results are consistent with the mode of action of the 
drug, which is to compete with xylose residues (attached to 
serines on the core proteins) for glycosyltransferases  that add 
the  next  sugar  of the  newly  initiated  glycosaminoglycan 
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35SO4 incorporated 
Without  With 
Compartment*  xyloside  xyloside  Ratio 
cpm/culture 
Culture medium  25,450  68,030  2.7 
Cell  layer  60,000  14,340  0.24 
Groups of duplicate  cultures  were  switched  to supplemented  N2  medium 
without or with  1 mM I~-xyloside  and  1 wk later were labeled for 18 h with 
35SO4 in  medium  without  or with  the  drug;  incorporated  radioactivity  was 
measured as described in Materials and Methods; numbers represent the aver- 
age of duplicate measurements; this experiment was repeated twice with identi- 
cal results. 
* The culture media were removed and mixed with protease inhibitors;  after 
washing, the cell layers were solubilized in 4 M guanidine-HC1, 0.1%  Triton 
X-100, 50 mM sodium acetate, pH 5,  10 mM EDTA, 0.5 mM phenylmethyl- 
sulfonyl fluoride. 
chains. This results in the synthesis of core proteins lacking 
glycosaminoglycan and also free glycosaminoglycan bound 
to the drug (26,  37).  The latter are unable to associate with 
the matrix and accumulate in the culture medium (37). 
These conclusions were confirmed by the results of gel 
filtration analysis performed on Sepharose CL-4B columns 
under dissociative conditions.  The cell-associated material 
from control cultures  was resolved into two major peaks, 
eluting at Kavs of '~0.2 and 0.4 (Fig.  1 a). We have shown 
previously that these represent the basement membrane and 
plasma membrane HS-PGs produced by Schwann cells (29). 
These peaks were dramatically reduced in the cell-associated 
material obtained from cultures treated with 1 mM 13-xylo- 
side (Fig.  1 c). Quantitation of the amounts of radioactivity 
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Figure  1.  Gel  filtration  chromatography of radiolabeled  macro- 
molecules from control and 13-xyloside-treated cultures. Schwann 
cell-nerve  cell  cultures  were  labeled  with  35SO4 and  the  cell- 
associated and culture medium macromolecules were subjected to 
gel filtration chromatography on Sepharose CL-4B columns as de- 
scribed  in  Materials  and  Methods.  (a)  Cell-associated  proteins 
from control cultures;  (b) culture medium from control cultures; 
(c) cell-associated proteins from cultures treated with 1 mM 13-xylo- 
side; (d) culture medium from cultures treated with 1 mM 13-xylo- 
side. In each case material from an equivalent number of cells was 
applied to the columns.  Recoveries were >85 %. 
E  -,! 
0  1.0  E  ,< 
a) 
~.,  0.5 ~ 
.0 
.5 
!  I  I 
0  0.5  1.0 
b 
12 
4 
0  0.5  1.0 
[xyloside  (mM)] 
0  0.5  1.0 
Figure 2. Concentration  dependence of ~xyloside effects on PG 
and glycosaminoglycan accumulation. Schwann cell-nerve cell cul- 
tures that had been grown for 1 wk in medium containing the indi- 
cated concentrations of ~xyloside were labeled with 35SO4 and the 
cell-associated and culture medium macromolecules were analyzed 
by gel filtration chromatography  as in Fig.  1.  All values are ex- 
pressed  relative to control values (without I~-xyloside). (a) Cell- 
associated  PGs;  (b)  culture  medium PGs;  (c)  culture  medium 
glycosaminoglycans. 
recovered from the column indicated that these HS-PGs were 
present at '~10% of their levels in control cultures. The cell- 
associated  material  from  the  13-xyloside-treated  cultures 
contained an additional peak that eluted at a K~ =  0.7 that 
was not present in the control cultures. The elution position 
of this peak was not altered by treatment with miM base. 
Digestion of this material with nitrous acid and chondroitin 
ABCase indicated it contained a mixture of heparan sulfate 
and chondroitin sulfate chains (not shown). Identical results 
were obtained in cultures treated with 13-xyloside for 2 wk 
(not shown). 
Gel filtration on Sepharose CL-4B of the medium from 
control cultures resulted in the elution of radiolabeled mac- 
romolecules in a broad region with several poorly resolved 
peaks (Fig. 1 b). Additional characterization of these macro- 
molecules  indicated  they  were  PGs  (data  not  shown).  In 
medium from cultures treated with 1 mM 13-xyloside, these 
peaks were absent and were replaced by a large sharp peak 
eluting at Kav =  0.7. (Fig.  1 d). This peak was insensitive to 
base hydrolysis but was degraded by nitrous acid, indicating 
it contained free HS chains (data not shown). 
Fig. 2  summarizes the effects of 13-xyloside tested at two 
concentrations  on the accumulation of cell-associated and 
medium PG and medium HS.  13-Xyloside inhibited HS-PG 
accumulation in the cell layer by 70% at 0.5 mM and 90% 
at 1 mM. 
~-Xyloside Inhibits Deposition of  Laminin 
into the Schwann Cell ECM 
To assess  the  effect of inhibition  of PG  synthesis  on the 
production  of basement membrane by Schwann  cells,  we 
used indirect immunofluorescence microscopy to compare 
the deposition of the glycoprotein laminin into ECM of con- 
trol  and  13-xyloside-treated  cultures.  Laminin  is  a  major 
structural component of basement membranes (39), includ- 
ing the basement membrane synthesized by cultured Schwann 
cells (11). As in the experiments described above, the drug 
was added to Schwann cell-nerve cell cultures at the time of 
switching from N2 medium to supplemented N2. 
In control cultures significant accumulation of laminin on 
the surfaces of the Schwann cells was evident by 4 d after the 
Carey et al. Proteoglycan  Synthesis  Inhibition  Effects on Differentiation  1015 Figure 3. Inhibition of laminin deposition is specific to 13-D-xyloside. Schwann cell-nerve cell cultures were switched to supplemented N2 
medium containing no additions  (A) or 1 mM concentrations  of 4-methylumbelliferyl-13-D-xyloside  (B),  ct-methyl-o-xyloside (C), or 
4-methylumbelliferyl-I~-I>glucoside (D). After 4 d the cultures were processed for indirect immunofluorescence with anti-laminin  antise- 
rum. The fields shown were photographed and printed under  identical conditions. 
medium switch (Fig. 3 A). By 8 d the cells were covered by 
a continuous layer of laminin (not shown). In contrast, in cul- 
tures given 1 mM 13-xyloside,  there was almost no laminin 
detectable on the surfaces of the Schwann cells at 4 d  (Fig. 
3 B); by 8 d  some laminin deposition had occurred, but it 
was sparse and patchy (not shown) in comparison to the con- 
trol cultures.  After 2  wk of 13-xyloside treatment,  laminin 
deposition was increased, but still was sparse in comparison 
to control cultures  (not shown). 
To demonstrate that this reduced laminin deposition was 
caused by inhibition of PG biosynthesis,  we examined the 
effects of compounds that were chemically similar to 13-xylo- 
side but that do not inhibit PG biosynthesis. As shown in Fig. 
3, addition of 1 mM methyl-ct-o-xyloside (Fig. 3 C) or 1 mM 
4-methylumbelliferyl-13-o-glucoside  (Fig.  3  D)  to  sup- 
plemented N2 did not inhibit the deposition of laminin into 
the Schwann cell ECM. 
The reduced laminin deposition demonstrated by immuno- 
fluorescence could have been caused either by an inability of 
secreted laminin to assemble into the basement membrane 
or by an inhibition of laminin synthesis and/or secretion as 
a result of 13-xyloside treatment. To determine which of these 
possibilities  was  occurring,  we  measured  the  amounts  of 
laminin present in the medium and cell layers of cultures 4  d 
after switching to supplemented N2 with or without  1 mM 
13-xyloside.  This was done by electrophoresing aliquots of 
medium or cell extracts in SDS-slab gels, electrophoretically 
transferring  the  proteins  to  nitrocellulose,  and  detecting 
bound laminin with antibodies. 
Consistent  with  the  immunofluorescence data presented 
above, the immunostained blots of cell-associated proteins 
showed a marked inhibition by I]-xyloside of laminin deposi- 
tion  (Fig.  4).  In  contrast,  the  blots  of medium  proteins 
showed  no  apparent  differences  between  the  control  and 
13-xyloside-treated  cultures.  Blots  of extracts  of cultures 
treated with 13-xyloside for 2 wk showed some laminin ac- 
cumulation, but much less than was observed in control cul- 
tures (not shown).  These results indicate that the failure of 
laminin deposition into ECM is not due to an inhibition of 
laminin synthesis or secretion. 
Treatment with 13-xyloside caused abnormal accumulation 
of free glycosaminoglycans in the culture medium (see Fig. 
1). To eliminate the possibility that this caused the observed 
inhibition  of matrix  assembly,  we  grew  cultures  in  sup- 
plemented N2 containing 50 ng/ml each of heparin and chon- 
droitin  sulfate.  This is  more than 20  times the  calculated 
concentration of glycosaminoglycan in the medium of 13-xy- 
loside-treated cultures. Addition of these molecules had no 
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secretion.  Schwann cell-nerve cell cultures were switched to sup- 
plemented N2 without (lanes 1 and 3) or with (lanes 2 and 4)  1 
mM I~-xyloside.  After 4 d the cell-associated proteins (lanes 1 and 
2) and conditioned  culture media (lanes 3 and 4) were subjected 
to electrophoresis  in 6% polyacrylamide gels, transferred to nitro- 
cellulose,  and stained with anti-laminin  antiserum as described in 
Materials and Methods. Lane 5 shows staining of authentic mouse 
laminin; lane 6 shows staining of rat kidney homogenate, revealing 
the specificity of the antiserum. The upper left arrow indicates the 
position of migration of the small (Mr =  200,000) subunit of lami- 
nin.  Under these conditions of transfer and staining the large (Mr 
=  400,000) subunit of laminin (right arrow, lane 5) is poorly de- 
tected.  The lower left arrow indicates an immunostained band of 
Mr  150,000 present  in the  Schwann cell  samples  that  may be a 
degradation  product of laminin. 
observable effects on deposition of laminin into the  ECM 
(data not shown). 
~-Xyloside Inhibits Accumulation of Collagen 
~ype IV in the Schwann Cell Basement Membrane 
The other major structural component of the Schwann cell 
basement membranes is collagen type IV (8). We conducted 
experiments to determine whether its assembly into base- 
ment membrane was also blocked by  ~xyloside.  Control 
cultures examined 1 wk after switching to supplemented N2 
exhibited bright, linear extracellular staining with anti-col- 
lagen type IV antibodies  (Fig.  5).  Staining of 13-xyloside- 
treated cultures was significantly reduced,  being absent in 
some areas and punctate  or fibrous in  other areas.  These 
results indicate that 13-xyloside treatment also blocks colla- 
gen type IV deposition into basement membrane. Other ex- 
periments indicated that secretion of collagen type IV was 
not inhibited by 13-xyloside treatment (not shown). 
Effects of  ~-Xyloside on Schwann Cell Spreading 
and Myelin Formation 
Previous studies have shown that formation of myelin seg- 
ments around  axons by  Schwann  cells  is  dependent  upon 
contact with a suitable ECM (6, 10, 30). In culture this is usu- 
ally the basement membrane synthesized by the  Schwann 
cells  (5).  Not  surprisingly,  in  13-xyloside-treated cultures 
there was a complete inhibition of myelin formation 2 wk af- 
ter switching to supplemented N2, when there were numer- 
ous  myelin  segments  present  in  the  control  cultures  (not 
shown). 
To determine whether 13-xyloside treatment had an effect 
on Schwann cell myelin formation separate from its effects 
on basement membrane assembly, we grew Schwann cell- 
nerve cell cultures in N2 medium containing both 13-xyloside 
and exogenous basement membrane (20).  We have shown 
previously that this exogenous basement membrane, which 
contains laminin, collagen type IV, and basement membrane 
PG in the proportions 35:1"1, plus small amounts of entactin 
(20),  can  substitute  for the  Schwann cell basement mem- 
brane in stimulating myelin formation (10). To ensure that the 
Schwann cells were depleted of the cell surface HS-PG, the 
cultures were grown for 2  d  in medium containing  1 mM 
[~-xyloside  before  addition  of exogenous  basement  mem- 
brane.  Pulse-chase  radiolabeling  experiments  had  shown 
that in cultures grown in N2 medium this HS-PG is degraded 
with a t.~ of '~9 h (not shown). Thus, after 48 h <5 % of the 
original HS-PG pool should remain. 
Previous studies have indicated that the first visible effect 
of basement membrane contact is the longitudinal spreading 
of Schwann cells onto axonal surfaces (7,  10). Light micro- 
scopic observation of the cultures revealed that 13-xyloside 
treatment did not inhibit Schwann cell spreading (Fig. 6 c). 
We attempted to quantitate the matrix-induced cell spreading 
by  measuring  the  diameters  of Schwann  cell  nuclei.  The 
spreading of Schwann cells causes a narrowing of their nu- 
clear diameters perpendicular to the neurite axis (7). The nu- 
clear diameters of control cultures without basement mem- 
brane  were  21.7  +  2.6  ~tm.  In  cultures  with  basement 
membrane the diameters were 10.5 +  1.9 and 10.9 +  1.9 Ixm, 
without  and  with  [~-xyloside.  Thus,  the  response  of the 
Schwann cells to basement membrane contact in I~-xyloside- 
treated cultures was not significantly different from that of 
Schwann cells in control cultures. 
To assess myelin formation,  cultures  were inspected by 
bright-field microscopy 2 wk after basement membrane ad- 
dition.  In the presence of exogenous basement membrane, 
~xyloside-treated  cultures  formed numerous  myelin seg- 
ments that  were indistinguishable  in  the  light microscope 
from those present in control cultures  (Fig.  6 d).  Average 
counts of numbers of myelin segments per field did not differ 
significantly  between  control  and  I~-xyloside-treated cul- 
tures (not shown). 
Discussion 
The data presented here have demonstrated that Schwann cell 
PG  biosynthesis  can be inhibited  90%  by treatment  with 
1 mM  4-methylumbelliferyl-13-D-xyloside.  In  our  experi- 
ments the basement membrane and plasma membrane HS- 
PGs produced by Schwann cells (9, 29) were equally affected 
Carey et al. Proteoglycan  Synthesis  Inhibition  Effects on Differentiation  1017 Figure 5.  13-Xyloside  inhibits collagen type IV deposition. Schwann cell-nerve cell cultures were switched to supplemented N2 without 
(A and B) or with (C and D) 1 mM 13-xyloside.  After 7 d the cultures were processed for indirect immunofluorescence with anti-collagen 
type IV antiserum. The fields shown in the figure were photographed with phase contrast (A and C) and fluorescence (B and D) optics. 
The fluorescence images shown in B and D were photographed and printed under identical conditions. 
by this inhibitor. Inhibition of HS-PG biosynthesis resulted 
in an inability of Schwann cells to assemble the basement 
membrane  they  would  normally  produce  in  culture  (5), 
which, in turn, resulted in an inhibition of myelin formation 
by the Schwann cells.  That the effect on myelin formation 
was due to the lack of  basement membrane was demonstrated 
by the observation that cultures given exogenous basement 
membrane were able to produce myelin in the presence of 
the inhibitor. The ability to form myelin in the presence of 
the drug also indicates that cell viability was not seriously 
affected by the long exposure time (2 wk) needed to observe 
myelin formation in culture. 
Our experimental protocol for studying the effects of the 
PG biosynthesis inhibitor involved first growing the cultures 
in the serum-free medium N2. In this medium the nerve cells 
produce neurites and the Schwann cells proliferate vigorous- 
ly in response to neurite contact (30, 35, 36). However, under 
these conditions no ECM material is deposited by the Schwann 
cells. As a consequence, Schwann cell terminal differentia- 
tion, which entails spreading along the neurites and ensheath- 
ment and myelination of the axons, does not occur (6, 7, 30). 
Previous studies have established that these processes do not 
occur in the absence of basement membrane contact (10). 
Production of basement membrane by the Schwann cells and 
subsequent terminal differentiation was initiated by growing 
the cultures in N2 medium supplemented with ascorbic acid 
and bovine serum albumin (Carey, D. J., and M.  S.  Todd, 
manuscript  submitted for publication).  By simultaneously 
providing the inhibitor and supplemented medium to the cul- 
tures, we were able to examine the effects of the inhibitor on 
Schwann cell terminal differentiation without the complica- 
tions of possible effects on such things as neurite outgrowth 
or Schwann cell proliferation. This was especially important 
in light of the recent report demonstrating that the neurite 
mitogen that stimulates Schwann cell proliferation may be a 
PG (34). In addition, we were able to investigate effects of 
inhibition on basement membrane assembly in the absence 
of preformed extracellular matrix. Because of the presumed 
cooperative nature of basement membrane assembly (43), 
the presence of basement membrane on the Schwann cell 
surface could have complicated the analysis and interpreta- 
tion of the experiments. 
The results presented here provide strong evidence that 
HS-PGs play an essential role in basement membrane assem- 
bly. Current models of basement membrane structure postu- 
late a framework consisting of a molecular lattice formed by 
collagen  type  IV  molecules  onto  which  other  basement 
membrane molecules attach through specific noncovalent in- 
teractions (24, 40, 43). Collagen type IV molecules are capa- 
ble of spontaneous  self-assembly into such a  network via 
noncovalent associations at their amino and carboxyl termi- 
nal ends (1, 12, 13). Basement membrane HS-PGs have been 
shown to bind in vitro to specific sites on both laminin and 
collagen type IV molecules (24). This raises the possibility 
that one function of basement membrane HS-PGs is to pro- 
vide cross-links between collagen and laminin that stabilize 
the molecular network formed by these two molecules. In the 
absence of HS-PG, e.g., in 13-xyloside-treated cultures, the 
lack of these cross-links would prevent the formation of sta- 
ble basement membrane structures. Alternatively, the bind- 
The Journal  of Cell Biology, Volume  105,  1987  1018 Figure 6. Effects of 13-xyloside and exogenous basement membrane on Schwann cells. Schwann cell-nerve cell cultures were grown for 
4 wk in N2 medium. Cultures were then given N2 medium alone (a), N2 medium plus exogenous basement membrane (b), or N2 medium 
plus 1 mM 13-xyloside and exogenous basement membrane (c and d). The latter cultures were given 13-xyloside 2 d before basement mem- 
brane addition (see text). Living cultures were photographed after 4 d with phase-contrast optics (a-c) or after 2 wk with bright-field optics 
(d).  Schwann cell nuclei are indicated by arrowheads. Note the change in Schwann  cell morphology elicited by the exogenous basement 
membrane both with and without 13-xyloside present.  The fibrillar noncellular material visible in b is in the collagen type I gel coating 
the culture dish and does not affect Schwann cell behavior. Schwann cells given exogenous basement membrane form myelin segments 
(arrows in d) in medium containing  1 mM 13-xyloside. 
ing of HS-PG to soluble laminin or collagen type IV could 
be a  rate-limiting step in the assembly process,  perhaps in- 
ducing a  conformational change in these molecules that ac- 
celerates their self-assembly. Indirect evidence for an effect 
of HS-PG binding on laminin conformation comes from the 
observation that antisera to laminin do not block the biologi- 
cal activity of laminin  complexed to HS-PG (22).  Finally, 
HS-PGs  may  be  involved  in  the  attachment  of basement 
membranes to the cell surface. In vivo basement membranes 
assemble only adjacent to specialized  surfaces of epithelial 
and other ceils. The attachment is often assumed to occur via 
interactions between laminin and specific cell surface recep- 
tors (15). A  putative laminin receptor has been identified  in 
several  laboratories  as  a  MT  =  70,000  cell  surface  glyco- 
protein (3, 25, 27, 31).  It is conceivable that integral cell sur- 
face HS-PGs, which have been identified in some basement 
membrane producing cells (18, 19, 32, 33), including Schwann 
cells (9), also function as receptors for laminin or other base- 
ment membrane proteins (23).  A  conclusion as to which of 
these  hypotheses  correctly  identifies  the  role  of HS-PGs 
awaits  further  investigation. 
Our results also indicate that the cell surface PG is not re- 
quired for basement membrane contact to elicit its develop- 
mental effects on Schwann cells.  Under conditions  in which 
the accumulation of this protein was reduced to 10% of con- 
trol levels exogenous basement membrane was still able to 
induce  spreading  onto  neurites  and  myelin  formation  by 
Schwann  cells.  Previously  we had  presented  evidence  that 
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Schwann cell cytoskeleton (9), which suggested a  role for 
this molecule in mediating these developmental effects. Sev- 
eral possible explanations of the data can be considered. The 
most likely is that the association of this HS-PG with the 
cytoskeleton has another functional consequence (perhaps 
related to regulation of basement membrane assembly). Al- 
ternatively, it is possible the low numbers of cell surface HS- 
PGs in 13-xyloside-treated cells were sufficient to carry out 
this  signalling  function.  However, in this case it is  likely 
there would have been quantitative differences in the extent 
or rate of cell spreading or myelin formation. Such differ- 
ences, if they existed, were not apparent in our studies. Fi- 
nally, Schwann cells may have redundant and functionally 
overlapping sets of receptors for transducing the effects of 
basement membrane contact on Schwann cell behavior. A 
definitive answer will require additional investigation into 
the identity and properties of basement membrane receptors 
in Schwann cells. 
If the cell surface HS-PG does play a role in regulating 
basement membrane assembly in Schwann cells, then its as- 
sociation with the cytoskeleton could potentially explain the 
asymmetric nature of this process. In developing peripheral 
nerves, basement membrane assembly occurs on regions of 
the Schwann cell surface not contacting axons (42).  Nerve 
cell contact is required, however, since only Schwann cells 
that are in contact with nerve cells assemble basement mem- 
brane  (4).  Thus,  basement membrane assembly,  plus the 
concomitant  shape  changes  induced  by  basement  mem- 
brane contact (10) result in the  Schwann cell and  its  en- 
sheathed axon becoming encased within a sleeve of  basement 
membrane (5, 42), and impose a structural and functional 
polarity on the Schwann cell surface. Obviously, some pro- 
cess must regulate spatially the process of basement mem- 
brane assembly. The association of the cell surface HS-PG 
with  the  cytoskeleton suggests  one mechanism  by  which 
specialized cell surface domains could be organized from 
within the cell in response to specific cues, such as adhesion 
of the cell to the surface membrane of an axon. 
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